TCL Archive Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer February 29, 2008
TCL Archive Conversation With The Cancer Letter: Seffrin To Retire After Restructuring ACS January 24, 2014